Company / Revenue per Share
Zoetis Revenue per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$21.11
FY2025
5-year range
$13.17 / $21.11
FY2021-FY2025
Trend
+4.5%
vs FY2024
Sector context
#28 of 154
Health Care
What the data says
Zoetis's revenue per share of $21.11 is higher than 82% of companies in the Health Care sector (FY2025). Revenue per Share has increased for 5 consecutive years, from $12.25 in FY2020 to $21.11 in FY2025.
Based on SEC 10-K filings.
21.11 in FY2025 with a 5-year CAGR of +11.5%. Top quartile in the Health Care sector.
Improved from $16.77 to $21.11 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- +14.3%
- 5-Year CAGR
- +11.5%
- 10-Year CAGR
- -
Sector benchmark
Top 18% in Health CareTop 18% of 154This company $21.11 Sector average $15.09
▼
+39.9% above sector average
Key checks
Key Insights
- Zoetis's revenue per share has grown for 5 consecutive years.
- In FY2025, revenue per share increased 4.5% year-over-year.
- Ranks #28 out of 154 companies in the Health Care sector.
- Lowest revenue per share in the period was in FY2016.
Company context
Key Data Points
- Strong profit margin: 28.2%
- Strong return on equity: 49.1%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $21.11 | +4.5% |
| FY2024 | $20.19 | +20.4% |
| FY2023 | $16.77 | +18.7% |
| FY2022 | $14.12 | +7.2% |
| FY2021 | $13.17 | +7.5% |
| FY2020 | $12.25 | -6.2% |
| FY2019 | $13.05 | +8.9% |
| FY2018 | $11.98 | +23.9% |
| FY2017 | $9.67 | +0.5% |
| FY2016 | $9.62 | +5.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026